AmericanPeptide
Catalog/PEG-MGF

PEG-MGF

Also known as Pegylated MGF · PEG Mechano Growth Factor · PEG-IGF-1Ec

A pegylated form of Mechano Growth Factor (MGF) designed for a longer half-life than the native IGF-1Ec splice peptide.

Research refreshed

Overview

PEG-MGF is Mechano Growth Factor — the IGF-1Ec splice variant released by mechanically loaded muscle — with a polyethylene-glycol (PEG) chain attached to extend its short half-life. Native MGF is cleared very quickly, so pegylation is used in research settings to keep the peptide in circulation long enough to study its proposed role in activating muscle satellite cells and local repair. It is a research compound, profiled here as the long-acting form of MGF; see the MGF entry for the underlying biology. It is not FDA-approved.

Background

MGF is the locally acting splice variant of IGF-1 that muscle produces in response to mechanical load; its distinctive E-domain is thought to activate the satellite cells that repair and grow muscle. Its practical problem as a research tool is speed of clearance — native MGF disappears from circulation almost immediately.

Pegylation is the standard fix: attaching a PEG chain shields the peptide and slows its removal, giving a longer-lived version for study. PEG-MGF is that long-acting form. The biology it is probing is MGF’s, and the evidence is preclinical; it is not FDA-approved. This page is a research and educational reference.

Mechanism

Same MGF signal — satellite-cell activation and local muscle repair via the E-domain of the IGF-1Ec splice variant — with a PEG chain that slows renal clearance and proteolysis to extend circulating half-life.

Key research findings

  • Long-acting MGF — pegylation extends the very short half-life of native MGF for research use.
  • Satellite-cell signal — carries the same IGF-1Ec E-domain activity proposed to drive local muscle repair.
  • Half-life engineering — a textbook use of PEG to stabilize a rapidly cleared peptide.
  • Preclinical — not FDA-approved; see the MGF entry for the base biology.

How PEG-MGF is made

Behind every vial of PEG-MGF is the same exacting pipeline every research peptide runs — but the chemistry plays out differently for this molecule. Here is how PEG-MGF, specifically, is brought into being.

  1. On paper first

    PEG-MGF begins not as a powder but as a specification. Before a single bond is made, the target sequence, salt form, and purity threshold are written down as the contract the finished material must meet.

  2. Built residue by residue

    PEG-MGF is assembled by solid-phase peptide synthesis — the chain grows one protected residue at a time on resin, and what you fail to build cleanly here you pay to remove later. It also carries PEGylation, an extra step beyond a plain chain that adds both capability and cost.

  3. Purity is won here

    The crude mixture — PEG-MGF plus its deletions and side products — is then separated on preparative HPLC, and where the cut is taken decides the difference between a genuinely pure peptide and a barely-passable one.

  4. Proven, then protected

    A real batch of PEG-MGF proves itself: identity confirmed by mass spectrometry, purity read directly off an analytical HPLC trace, water and counterion content measured. That batch-specific certificate of analysis is the only honest way to know what is actually in a vial of PEG-MGF — and a short, cold, accountable chain of custody is how that purity survives the trip to your bench.

Walk the full synthesis pipeline

Handling, storage & why purity is hard

The MGF backbone is a ~24-residue peptide made by solid-phase synthesis, but the hard, poorly-standardized step is the PEG conjugation — the attachment site and PEG size determine the product, and “PEG-MGF” materials vary widely in how (and whether) the PEG is actually coupled. Identity work has to characterize the conjugate, not just the peptide, which is rarely disclosed on product pages.

Demanding synthesis
Storage
Store lyophilized, frozen, and protected from light; keep reconstituted peptide cold and use within a short window. The PEG conjugate is sensitive to the same heat and agitation stresses as the underlying peptide.
Handling
Reconstitute gently without vortexing. Identity work should characterize the PEG conjugate — attachment site and PEG size — not just the MGF peptide backbone.

Don't judge a vial by its cake. A fluffy, good-looking lyophilized powder reflects bulking agents and freeze-drying parameters — not purity. Insist on a batch-specific certificate of analysis.

How peptides are made — the full pipeline

Research areas

  • Muscle repair and hypertrophy (preclinical)
  • Satellite-cell activation
  • Peptide half-life engineering

Latest research

Recent clinical trials and publications mentioning PEG-MGF, pulled automatically from ClinicalTrials.gov and PubMed and refreshed daily. Listings are unfiltered search results, not curated endorsements.

Frequently asked questions

What is PEG-MGF?+

Mechano Growth Factor (the IGF-1Ec splice peptide) with a PEG chain attached to extend its otherwise very short half-life for research use.

Why pegylate MGF?+

Native MGF is cleared almost immediately; the PEG chain slows clearance and proteolysis so the peptide stays in circulation long enough to study.

How is it different from MGF?+

Same signaling peptide and proposed biology — the difference is the pegylation that makes PEG-MGF longer-acting. See the MGF entry for the base science.

Is it approved?+

No — it is a research compound, not FDA-approved. This page is a research and educational reference.

Related peptides

Peptide Agent

Ask the Agent about PEG-MGF

Dosing protocols, mechanism, comparisons, and the latest trials — citation-backed answers grounded in PubMed, PubChem, and ClinicalTrials.gov.